CD5 and T-cell non-Hodgkin lymphoma: These studies have investigated CD4−, CD5−, CD7, and TRBC1-specific CAR-T cells for r/r T cell leukemias and lymphomas and CD30-specific CAR-T cells for r/r T cell lymphomas.